February 2026 in “Austrian Journal of Technical and Natural Sciences” This study investigated the effects of mesotherapy on alopecia in patients who had bariatric surgery, highlighting significant roles of individual, behavioral, and structural factors, though specific results were not fully detailed in the abstract.
February 2026 in “Journal of Drugs in Dermatology” In this series, patients experienced alopecia with limited regrowth following mesotherapy, indicating possible lasting aesthetic consequences and suggesting the need for careful technique and close follow-up, as the condition might be underrecognized.
January 2026 in “Dermatologic Therapy” This study found that in patients with female androgenetic alopecia, mesodermal injection of 0.5% minoxidil was more effective in increasing hair density and improving hairline height than topical 2% minoxidil, with comparable safety over 16 weeks.
January 2026 in “Clinical Cosmetic and Investigational Dermatology” This study found that mesotherapy with placenta polypeptide injection significantly reduced skin inflammation and improved aesthetic outcomes in adults with moderate-to-severe sensitive skin, without increasing adverse events compared to controls.
November 2025 in “Dermatological Reviews” This study found that eyebrow mesotherapy with a growth factor-based serum improved eyebrow width, length, density, and psychosocial outcomes such as social engagement, quality of life, confidence, and mood in individuals with sparse or weakened eyebrows.
October 2025 in “Brazilian Journal of Case Reports” This case report suggests that combining platelet-rich plasma therapy with mesotherapy may effectively increase hair density and improve scalp health in complex cases of androgenetic alopecia.
This study found that combining oral minoxidil, oral dutasteride, and dutasteride mesotherapy was the most effective treatment for androgenetic alopecia, with improved outcomes at 12 months and a favorable safety profile, compared to other treatment combinations.
August 2025 in “SciELO (SciELO Preprints)” In this review, the authors assessed the efficacy of mesotherapy for alopecia treatment, finding that combining mesotherapy with minoxidil, PRP, or growth factors significantly improves hair density and thickness but noted the need for standardized protocols and larger studies to confirm long-term effectiveness.
January 2025 in “Acta Scientific Women s Health” This review examines the diverse uses of mesotherapy in dermatology, noting its efficacy in enhancing skin hydration and treating conditions such as hyperpigmentation, hair loss, and acne scarring, while highlighting its potential to optimize overall skin health.
October 2024 in “JAAD Case Reports” In this retrospective analysis, dutasteride mesotherapy was used in 10 patients with androgenetic alopecia and resulted in hair density and width changes measured at the scalp, but specific efficacy results are not detailed in the abstract.
September 2024 in “Indian Journal of Dermatology Venereology and Leprology” Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
August 2024 in “JEADV Clinical Practice” In this clinical trial, 16 women with frontal fibrosing alopecia experienced significant improvements in hair density, vellus hair count, and quality of life after monthly intralesional dutasteride treatments, though larger and longer-term studies are needed to confirm these findings.
July 2024 in “Skin Research and Technology” This study found that combining Bioscalp with Ultra Exo Booster and Ultra S Line Plus significantly promoted hair growth and maintained hair bulb integrity in cultured hair follicles from Korean adults.
June 2024 in “Skin Appendage Disorders” In this study, injections of PRP and MZT products significantly improved hair thickness, density, and count in AGA patients over six months, with variability observed in the extent of improvement between different formulations.
This study found that mesotherapy combined with minoxidil for androgenetic alopecia shows promise with high patient satisfaction and manageable risks, though some uncommon side effects may occur.
In this study, researchers found that adding zygomaticotemporal nerve blocks to supratrochlear and supraorbital nerve blocks in mesotherapy lowered pain significantly during and after the procedure for hair regrowth in alopecia patients.
September 2023 in “Forum Dermatologicum” Dutasteride injections can help treat hair loss in men and women.
August 2023 in “Journal of Dermatological Treatment” This systematic review concluded that mesotherapy shows potential for improving hair growth outcomes, yet lacks standardized regimens and requires further large-scale trials to establish its efficacy and safe use.
June 2023 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.
February 2023 in “European Journal of Dermatology” In this retrospective study from North France, apremilast was used in patients with psoriasis and recent cancer, showing a good safety profile and improved quality of life, though with 65.2% experiencing non-serious adverse events. The need for further research on oncological safety was highlighted.
September 2022 in “Journal of Plastic and Reconstructive Surgery” This article discusses the public interest in mesotherapy for rejuvenation, noting inconsistent evidence of its efficacy, and suggests that revised standards for injection depth may improve patient outcomes.
Combining mesotherapy and PRP effectively treats hair loss in women.
January 2022 in “Goce Delchev University Repository (Goce Delčev University of Štip)” In this case report, researchers treated three women experiencing hair loss with a combination of mesotherapy and PRP hair treatments, resulting in satisfactory hair improvement with minimal side effects.
December 2021 in “Journal of clinical images and medical case reports” This review compares mesotherapy and PRP for hair loss but reports no new clinical results; the authors highlight the need to understand their differences for optimal treatment choices.
September 2021 in “Farmacja Polska” In this summary of needle mesotherapy's role in treating alopecia, the researchers highlight its use in delivering beneficial substances directly to the skin or hair follicles, showing hair loss reduction after one treatment and hair regrowth after several sessions, although contraindications exist for certain populations.
March 2021 in “CRC Press eBooks” This review discusses the application of mesotherapy in dermatology and trichology, noting its potential benefits and issues, but reports no new clinical results.
This study summarizes the therapeutic use of mesotherapy using vitamins, trace elements, and stem cell extracts for treating alopecia, noting its effectiveness in addressing both androgenetic alopecia and telogen effluvium as demonstrated in various clinical trials.
January 2018 in “Archives of dermatology and skin care” This review discusses the lack of adequate clinical trials evaluating the efficacy and safety of mesotherapy for cosmetic hair loss and reports no new results.
August 2015 in “Journal of clinical & experimental dermatology research” This review discusses the use of mesotherapy and PRP for hair loss and reports no new clinical results; the authors note widespread media attention and call for further studies on efficacy.
January 2015 in “Indo American Journal of Pharmaceutical Research” This article describes mesotherapy, a technique involving small doses of compounds injected into the skin for cosmetic uses like aging skin and fat reduction, and provides no new clinical results.